-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the evaluation results of adverse drug reactions, in order to further protect the safety of public medication, the National Medical Products Administration has decided to revise the instructions for mouse nerve growth factor for injection [adverse reactions], [precautions] and medication items for special populations
1.
If the revised content involves the label of a drug, it shall be revised together; the instructions and other content of the label shall be consistent with the original approved content
2.
3.
4.
5.
Hereby announce
Attachment: Revision requirements of the instructions for mouse nerve growth factor for injection
State Food and Drug Administration
March 18, 2021
Annex to Announcement No.